Use of a triple helix-forming oligodeoxynucleotides as a novel therapeutic strategy for ERB-B2 positive breast cancer

Average Rating

Author

Dolan, C

Publisher

Varies, see individual formats and editions

Publication Date

1998

Language

English

Print Material
 Show Edition

On Shelf

1 copies available.

SEE ALL LOCATIONS

See Full Copy Details

Place Hold

Add a ReviewAdd to List

SHARE